These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9689898)
1. Influence of neuroleptics on cytotoxic activity of macrophages in rats. Madej A; Belowski D; Kowalski J; Herman ZS Boll Chim Farm; 1998 May; 137(5):135-9. PubMed ID: 9689898 [TBL] [Abstract][Full Text] [Related]
2. Influence of antidepressant drugs on macrophage cytotoxic activity in rats. Belowski D; Kowalski J; Madej A; Herman ZS Pol J Pharmacol; 2004; 56(6):837-42. PubMed ID: 15662098 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms. Daniel WA; Haduch A; Wójcikowski J Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279 [TBL] [Abstract][Full Text] [Related]
4. Effects of haloperidol and chlorpromazine on smooth muscle contractility, platelet aggregation and neuronal calcium current. Prokopenko RA; Mogilevich SE; Luik AI; Naydyenova IY; Batrak GN; Hawryluk BR; Degtiar VY Gen Physiol Biophys; 1995 Aug; 14(4):349-57. PubMed ID: 8720698 [TBL] [Abstract][Full Text] [Related]
5. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes. Daniel WA; Kot M; Wójcikowski J Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101 [TBL] [Abstract][Full Text] [Related]
6. Neuroleptics modulate cytokine and reactive oxygen species production in blood leukocytes of healthy volunteers. Szuster-Ciesielska A; Słotwińska M; Stachura A; Marmurowska-Michałowska H; Kandefer-Szerszeń M Arch Immunol Ther Exp (Warsz); 2004; 52(1):59-67. PubMed ID: 15053234 [TBL] [Abstract][Full Text] [Related]
7. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration. Kulkarni SK; Bishnoi M; Chopra K Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163 [TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with atypical neuroleptics sulpiride and metoclopramide increases striatal enkephalins in rat brain. Herman ZS; Huzarska M Pol J Pharmacol; 1993; 45(5-6):493-502. PubMed ID: 8012472 [TBL] [Abstract][Full Text] [Related]
9. Differential behavioural effect of quinpirole in neuroleptic-pretreated rats - role of alpha(1)-adrenoceptor. Obuchowicz E Eur J Pharmacol; 1999 Nov; 384(2-3):101-9. PubMed ID: 10611430 [TBL] [Abstract][Full Text] [Related]
10. Dopamine metabolism in the rat retina and brain after acute and repeated treatment with neuroleptics. Scatton B; Dedek J; Korf J Adv Biochem Psychopharmacol; 1978; 19():373-5. PubMed ID: 29452 [No Abstract] [Full Text] [Related]
11. Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice. Simón VM; Parra A; Miñarro J; Arenas MC; Vinader-Caerols C; Aguilar MA Eur Neuropsychopharmacol; 2000 May; 10(3):159-64. PubMed ID: 10793317 [TBL] [Abstract][Full Text] [Related]
12. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia. Bishnoi M; Chopra K; Kulkarni SK Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104 [TBL] [Abstract][Full Text] [Related]
13. Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures. Labuzek K; Kowalski J; Gabryel B; Herman ZS Eur Neuropsychopharmacol; 2005 Jan; 15(1):23-30. PubMed ID: 15572270 [TBL] [Abstract][Full Text] [Related]
14. Changes in chlorpromazine induced CNS effects when associated with other neuroleptics and anxiolytics. Pérez-Raya MD; Risco S; Navarro C; Jimenez J; Cabo J Pharm Acta Helv; 1989; 64(5-6):146-50. PubMed ID: 2569203 [TBL] [Abstract][Full Text] [Related]
15. Chronic treatments with haloperidol and clozapine alter the level of NMDA-R1 mRNA in the rat brain: an in situ hybridization study. Ossowska K; Pietraszek M; Wardas J; Dziedzicka-Wasylewska M; Nowicka D; Wolfarth S Pol J Pharmacol; 2002; 54(1):1-9. PubMed ID: 12020038 [TBL] [Abstract][Full Text] [Related]
16. Electrocortical spectrum power effects of different classes of neuroleptics in rats. Bagetta G; Corasaniti MT; Strongoli MC; Sakurada S; Nisticò G J Psychiatr Res; 1987; 21(1):93-9. PubMed ID: 2882023 [TBL] [Abstract][Full Text] [Related]
17. [Removal of the optimizing action of neuroleptics on the avoidance behavior of rats after striatectomy]. Arushanian EB; Baturin VA Farmakol Toksikol; 1979; 42(3):230-4. PubMed ID: 36296 [TBL] [Abstract][Full Text] [Related]
18. Classical neuroleptics and deconditioning activity after single or repeated treatment. Role of different cerebral neurotransmitters. Fregnan GB; Chieli T Arzneimittelforschung; 1980; 30(11):1865-70. PubMed ID: 6109537 [TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of p-Nitrobenzoic Acid (CAS No. 62-23-7) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 442():1-306. PubMed ID: 12595921 [TBL] [Abstract][Full Text] [Related]
20. Effect of haloperidol treatment on immunoreactive neuropeptide Y secretion into lateral cerebral ventricle of rats. Obuchowicz E; Stachura Z Pol J Pharmacol; 2000; 52(3):223-7. PubMed ID: 11055580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]